会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • 新規光安全性試験法
    • 新型光学安全测试方法
    • JP2016102722A
    • 2016-06-02
    • JP2014241412
    • 2014-11-28
    • 一般財団法人 化学物質評価研究機構
    • 武吉 正博前田 洋祐
    • G01N33/50G01N33/15
    • 【課題】体系的で信頼性のある光安全性試験を提供する。 【解決手段】(1)被験物質のUV吸収スペクトル測定を行い、光毒性及び光アレルギー性試験の実施の要否を決定し、(2)皮膚感作性評価において、被験物質試験群が、対照物質試験群に対して3倍の皮膚感作性を示す前記被験物質の濃度の算出を行い、(3)光毒性評価において、(3−i)前記(2)で算出した前記被験物質濃度において、光ハプテン型試験及びプロハプテン型試験の2通りのUV照射方法で光毒性試験を行い、より感作性の高い試験方法を選択し、(3−ii)選択された前記UV照射方法において、前記被験物質について光毒性試験を行い、皮膚感作及び光毒性を生じない最高濃度を決定し、(4)光アレルギー性評価において、前記(3−i)において選択されたUV照射方法を用い、前記(3−ii)において決定された濃度で、前期被験物質の光アレルギー性を評価する光安全性試験方法。 【選択図】図1
    • 要解决的问题:提供系统可靠的光学安全测试方法。解决方案:通过光学安全测试方法,(1)测量被测材料的紫外吸收光谱,以确定光学毒性和光学过敏测试 诱导需要进行; (2)在皮肤敏感性评价中,计算出测试材料组中如试验材料对照组中表现为皮肤敏感性敏感度为3倍的测试材料的浓度; (3)在光学毒性评估(3-i)中,通过两种不同的紫外线照射方法(包括光学半抗原类型法和催眠型法)选择在上述(2)中计算的测试材料的浓度来测试光学毒性,以选择 两种方法和(3-ii)通过选择的UV照射方法更敏感,评估测试材料的光学毒性以确定皮肤敏感性和光学毒性都不发生的最大浓度; 和(4)在光学过敏评价中,通过上述(3-i)所述的紫外线照射方法,用上述(3-ii)所述测定的浓度对被测物质的光学过敏诱导性能进行评价。 图1
    • 2. 发明专利
    • Angiogenesis regulator and utilization thereof
    • 血管生成调节因子及其利用
    • JP2013001675A
    • 2013-01-07
    • JP2011133895
    • 2011-06-16
    • Hiroshima Univ国立大学法人広島大学Chemicals Evaluation & Research Institute Japan一般財団法人 化学物質評価研究機構
    • MATSUBARA CHIKANORITAKEYOSHI MASAHIROYOKOTA HIROFUMI
    • A61K48/00A61K31/7088A61K31/7105A61K38/00A61K45/00A61P3/10A61P9/10A61P9/14A61P19/02A61P29/00A61P35/00C12N15/09C12N15/113C12Q1/02C12Q1/68
    • PROBLEM TO BE SOLVED: To provide an angiogenesis promoter, a method for promoting angiogenesis, an angiogenesis inhibitor, a method for inhibiting angiogenesis, and a method for screening an angiogenesis regulation composition in each of which novel genes involved in the mechanism of regulating angiogenesis are utilized.SOLUTION: The angiogenesis promoter comprises as an active ingredient a polynucleotide containing the base sequence shown in sequence No.1 (NCBI Accession No. AB044755) or a like polynucleotide, a polypeptide containing the amino acid sequence shown in sequence No.2 (NCBI Accession No. BAA96781) or a like polypeptide, an inhibitor of a polynucleotide containing the base sequence shown in sequence No.3 (NCBI Accession No. AB077880) or a like inhibitor, or an inhibitor of a polypeptide containing the amino acid sequence shown in sequence No.4 (NCBI Accession No. BAB83896) or a like inhibitor. The angiogenesis inhibitor comprises as an active ingredient an inhibitor of a polynucleotide containing the amino acid sequence shown in sequence No.1 (NCBI Accession No. AB044755) or a like inhibitor, an inhibitor of a polypeptide containing the amino acid sequence shown in sequence No.2 (NCBI Accession No. BAA96781) or a like inhibitor, a polynucleotide containing the base sequence shown in sequence No.3 (NCBI Accession No. AB077880) or a like polynucleotide, or a polypeptide containing the amino acid sequence shown in sequence No.4 (NCBI Accession No. BAB83896) or a like polypeptide.
    • 待解决的问题:提供血管生成促进剂,促进血管发生的方法,血管生成抑制剂,抑制血管发生的方法,以及筛选血管生成调节组合物的方法,其中每一种参与机制的新基因 利用调节血管发生。 解决方案:血管生成促进剂包含含有序列号1所示的碱基序列(NCBI登录号AB044755)等的多核苷酸作为活性成分,含有序列号2所示的氨基酸序列的多肽 (NCBI登录号BAA96781)或类似多肽,含有序列号3所示碱基序列的多核苷酸的抑制剂(NCBI登录号AB077880)等抑制剂,或含有氨基酸序列的多肽的抑制剂 如序列号4(NCBI登录号BAB83896)或类似的抑制剂。 血管生成抑制剂含有含有序列号1所示氨基酸序列(NCBI登录号AB044755)等的抑制剂作为活性成分的抑制剂,含有序列号No所示的氨基酸序列的多肽的抑制剂 (NCBI登录号BAA96781)等抑制剂,含有序列号3所示碱基序列的多核苷酸(NCBI登录号AB077880)等多核苷酸,或含有序列号No所示的氨基酸序列的多肽 .4(NCBI登录号BAB83896)或类似多肽。 版权所有(C)2013,JPO&INPIT
    • 5. 发明专利
    • Device and method for filling column for high-performance liquid chromatography
    • 用于高性能液相色谱填充色谱柱的装置和方法
    • JP2007298455A
    • 2007-11-15
    • JP2006127945
    • 2006-05-01
    • Chemicals Evaluation & Research Institute財団法人化学物質評価研究機構
    • SAKAMAKI HIROSHI
    • G01N30/56G01N30/88
    • PROBLEM TO BE SOLVED: To provide a device and method for filling a column for high-performance liquid chromatography (HPLC), capable of shortening remarkably a time for returning residual pressure in the filling device to atmospheric pressure after finishing filling, and capable of enhancing preparation efficiency of the column for the HPLC.
      SOLUTION: The device 2 for filling the column 4 for the HPLC having a high-pressure liquid feed pump 8, and a liquid feed pipe 10 for connecting the pump 8 to a packer 6, includes a flow-dividing resistance tube 12 in the liquid feed pipe 10, a high-pressure liquid feed pump 8 delivery side or a packer 6 upper side. In this filling method using the device 2, a slurry dispersed with a bulking agent in a solvent is supplied to the packer 6, the liquid is fed thereafter to the packer 6 at 10-100 MPa of pressure by the high-pressure liquid feed pump 8, and the bulking agent is filled into the column 4 while discharging the liquid from the flow-dividing resistance tube 12.
      COPYRIGHT: (C)2008,JPO&INPIT
    • 要解决的问题:提供一种用于填充用于高效液相色谱(HPLC)的柱的装置和方法,其能够在完成填充之后显着缩短将填充装置中的残余压力恢复到大气压力的时间,以及 能够提高HPLC柱的制备效率。 解决方案:用于填充具有高压液体供给泵8的HPLC的柱4的装置2和用于将泵8连接到封隔器6的液体供给管10包括分流阻力管12 在液体供给管10中,高压液体供给泵8输送侧或封隔器6的上侧。 在使用装置2的这种填充方法中,将在填充剂中分散的浆料溶解在封隔器6中,然后通过高压液体供给泵在10-100MPa的压力下将液体供给到封隔器6 8,在从分流阻力管12排出液体的同时将填充剂填充到塔4中。(C)2008,JPO&INPIT
    • 9. 发明专利
    • Method for rating sensitizing potential intensity of test chemical substance
    • 评价测试化学物质的敏感性强度的方法
    • JP2005095080A
    • 2005-04-14
    • JP2003333984
    • 2003-09-25
    • Chemicals Evaluation & Research Institute財団法人化学物質評価研究機構
    • TAKEYOSHI MASAHIRO
    • G01N33/15C12Q1/02C12Q1/68
    • PROBLEM TO BE SOLVED: To provide a method for more accurately determining the sensitizing potential intensity of a test chemical substance in a short time. SOLUTION: The method for rating the sensitizing potential intensity of a test chemical substance comprises the step(1) of preparing a standard solution(A) made by dissolving a standard chemical substance with known sensitizing potential intensity to a specified concentration and a test solution(B) made by dissolving a test chemical substance to the same concentration as that for the standard solution(A), the step(2) of applying the solution(A) to a group of control test animals and the solution(B) to a group of test animals, the step(3) of sampling the auricular lymph nodes of each of the test animals and assaying an indicator representing the cell proliferation extent of each of the auricular lymph nodes, and the step(4) of making a relative comparison of an indicator representing the cell proliferation extent of the auricular lymph nodes for the control test animal group and that for the test animals. COPYRIGHT: (C)2005,JPO&NCIPI
    • 要解决的问题:提供一种用于在短时间内更准确地确定测试化学物质的敏化势强度的方法。 评价试验化学物质的敏化势强度的方法包括制备通过将具有已知敏化电位强度的标准化学物质溶解至规定浓度而制备的标准溶液(A)的步骤(1) 通过将测试化学物质溶解成与标准溶液(A)相同的浓度制备的测试溶液(B),将溶液(A)施用于一组对照试验动物的步骤(2)和溶液(B )给一组试验动物,对每个试验动物的耳淋巴结进行取样的步骤(3),并测定表示每个耳状淋巴结的细胞增殖程度的指标,以及制备步骤(4) 表示对照试验动物组和试验动物组的耳淋巴结细胞增殖程度的指标的相对比较。 版权所有(C)2005,JPO&NCIPI